Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Eoganacht


V.TLT

RE:RE:RE:RE:One more look at the new 90 day optimized data

Even 25%-30% CR at 450 days is a much better result than that achieved by the...

April 28, 2022

V.TLT

RE:RE:One more look at the new 90 day optimized data

Great analysis. 54% CR at  450 days is 24% higher than the FDA benchmark...

April 28, 2022

V.TLT

RE:RE:RE:RE:RE:Half Of Breakthrough Designations Have Resulted In Approval

According to the projected timeline on slide 12 of the corporate presentation...

April 27, 2022

V.TLT

The Theralase Project

It's easy to underestimate the difficulty of what Theralase is trying to...

April 26, 2022

V.TLT

UTA Magazine Winter 2022

A LIGHT APPROACH Sherri McFarland, professor of chemistry, is shedding...

April 25, 2022

V.TLT

RE:RE:RE:RE:RE:BTD timeline...

Hi Pandora, What I meant by the '25th patient" is the 25th patient...

April 24, 2022

V.TLT

RE:RE:RE:BTD timeline...

My mistake. Dr. Jewett didn't mention the 67% in the 2018 BTV segment...

April 24, 2022

V.TLT

RE:RE:BTD timeline...

I believe that 67% number came out of a conversation between Theralase and...

April 24, 2022

T.PYR

MidtownGuy Speaks!

Echoing Thinkbigsti69 - the best CEO.CA PYR poster/sleuth is now a company...

April 21, 2022

V.TLT

UTA Voices Podcast Episode with Dr. McFarland now available

48 minute talk taped earlier today: Voices Live :: Talking Chemistry with...

April 19, 2022

V.TLT

One more look at the new 90 day optimized data

I changed the percentages to patient counts for the recent 90 day numbers for...

April 18, 2022

V.TLT

New President of American Society for Photobiology

ASP news - March 2022 4 April at 22:57   Thanks to all who cast...

April 18, 2022

V.TLT

RE:Roger buying again

He bought 32,000 more shares today. That's 52,000 shares this month so...

April 18, 2022

V.TLT

RE:Dr. McFarland to Talk Tomorrow

I heard back from the University of Maryland. The best way to attend this...

April 14, 2022

V.TLT

Dr. McFarland to Talk Tomorrow

If you happen to be in the Washington DC area tomorrow, Dr McFarland will be...

April 14, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:$tltff The FDA wants an option that has rates better then

I think there are a number of reasons for that. A common problem with new...

April 13, 2022

V.TLT

RE:RE:RE:$tltff The FDA wants an option that has rates better then

That's better than the (Keytruda superior) CR results of the1990's...

April 12, 2022

V.TLT

Bladder Cancer Clinical Trial Listing for Patients

Bladder Cancer studies recruiting patients for novel treatments TLD-1433...

April 11, 2022

V.TLT

RE:RE:RE:RE:RE:Signing up new trial patients

Hopefully there will be a way to get to TLD1433 pdt as a first-line treatment...

April 8, 2022

V.TLT

RE:RE:RE:Signing up new trial patients

Great posts Gman620. It's important to think about how this all looks...

April 8, 2022